mRNA
TopicHeard in 11 episodes across 10 shows since Mar 2026
Messenger RNA is a type of RNA that carries genetic instructions from DNA to ribosomes, where they guide the production of proteins; mRNA technology is used in vaccines and other medical treatments.
Episodes
First heard
Expert statements
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 1 |
| Apr 2026 | 1 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 2 |
| Sep 2026 | 2 |
| Oct 2026 | 2 |
| Nov 2026 | 3 |
Email alert
Email me when mRNA comes up on a podcast
One email a week at most, with the new episodes that mention mRNA. Free, no account needed, unsubscribe in one click.
What experts have said about mRNA
6 statements · 5 positive · 1 neutral
mRNA vaccines may provide immunotherapy benefits independently.
“there is growing evidence that mRNA vaccines, like even COVID vaccines, can provide a immunotherapy benefit on their own”
Open the episode · Episode 199 - October 16, 2026Listen at 55:55
mRNA vaccines may provide immunotherapy benefits independently of antigen specificity.
“there is growing evidence that mRNA vaccines, like even COVID vaccines, can provide a immunotherapy benefit on their own”
Open the episode · Episode 199 - October 16, 2026Listen at 55:55
Positive melanoma results raised hopes for mRNA treatments beyond COVID-19.
“it raised hopes about the mRNA's second act here after COVID.”
Open the episode · Paypal Sinks on Abandoned Deal, Affirm Rallies, BioNTech SlumpsListen at 3:46
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
11 episodes featuring mRNA, newest first
- Nov 17, 2026
Silicon Valley’s accountability crisis reaches national securityPivotNov 17, 2026 - Nov 17, 2026
Biotech bets meet a pivotal FDA succession fightBioCentury This WeekNov 17, 2026 - Nov 16, 2026
Personalized vaccines cut melanoma recurrence riskThe DailyNov 16, 2026 - Oct 26, 2026
AI boom tests markets as executives confront recovery and cyber riskMad Money w/ Jim CramerOct 26, 2026 - Oct 15, 2026
Moderna rallies as Dell stumbles and BNY beats expectationsStock MoversOct 15, 2026 - Sep 15, 2026
Biotech’s promise collides with weak oversightSarah Westall - Business Game ChangersSep 15, 2026